P641 - IS NUTRITION OVERLOOKED IN INFLAMMATORY BOWEL DISEASE, WHICH TEST IS SUPERIOR IN NUTRITIONAL ASSESSMENT?

P641

IS NUTRITION OVERLOOKED IN INFLAMMATORY BOWEL DISEASE, WHICH TEST IS SUPERIOR IN NUTRITIONAL ASSESSMENT?

T. METİN^1,*, R. KORKMAZ², M. KARAÇALI², A. BALKAN¹

¹Gastroenterology, ²Internal Medicine, Gaziantep University School of Medicine, Gaziantep, Türkiye

Rationale: The involvement of the gastrointestinal tract has encouraged the investigation of the relationship between nutrition and inflammatory bowel disease (IBD). Different tests are used to assess nutritional status in these patients and it was tried to determine which one is more appropriate (1).

Methods: A total of 323 patients with ulcerative colitis (UC), Crohn's disease (CD) and celiac disease in remission who were admitted to Gaziantep University School of Medicine IBD outpatient clinic were included in the study. The mini nutritional assessment test short form (MNA-SF) and MUST score were used to assess nutritional status.

Results: The mean age of the patients was 38.1 years. UC was diagnosed in 35.6%, CD in 36.5% and celiac disease in 27.9% of the patients. 5.2% of UC patients, 9.3% of CD patients and 13.3% of celiac patients were in the high-risk group for malnutrition according to MUST score. According to the MNA-SF test, 29.6% of UC patients were malnourished or at risk of malnutrition. This compared to 19.5% for CD patients and 34.4% for celiac disease. Celiac patients were significantly more at risk for malnutrition according to both MUST and MNA-SF scores (p:0.090) (p:0.017). In UC patients with pancolitis involvement, the rate of malnutrition according to MNA-SF score was higher than other subtypes (p:0.022). No similar relationship was observed in MUST score (p:0,126). 

Conclusion: Different scoring systems are preferred for nutritional assessment in IBD patients, and the MNA-SF test should be used especially in UC patients as it better reflects the difference according to the type of involvement.

References: 1-[ESPEN guideline: Clinical nutrition in inflammatory bowel disease]. Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Forbes A, Montoro M, Burgos Peláez R.
Nutr Hosp. 2022 Jun 24;39(3):678-703.

Disclosure of Interest: None declared